Division of Applied Life Science, Graduate School of Engineering, Sojo University, Kumamoto, Japan.
Biol Pharm Bull. 2011;34(6):901-5. doi: 10.1248/bpb.34.901.
Therapeutic effects of hybrid liposomes (L-α-dimyristoylphosphatidylcholine (DMPC)/docosahexaenoic acid (DHA)) composed of 50 mol% DMPC and 50 mol% DHA on the metastasis of human colon carcinoma (HCT116) cells were examined in vivo. DMPC/DHA having a hydrodynamic diameter less than 100 nm were preserved for one month. Remarkably high therapeutic effects were obtained in the hepatic metastasis mouse models of HCT116 cells after the intravenous injection of DMPC/DHA. The histological analysis indicated the induction of apoptosis was observed in the liver section of the hepatic metastasis mouse models treated with DMPC/DHA in vivo. Furthermore, prolonged survival was obtained in the hepatic metastasis mouse models after the treatment with DMPC/DHA. Therapeutic effects of DMPC/DHA without any drugs on the hepatic metastasis were revealed on the basis of histological and biochemical analyses for the first time in vivo.
体内研究了由 50mol%DMPC 和 50mol%DHA 组成的混合脂质体(L-α-二肉豆蔻酰磷脂酰胆碱(DMPC)/二十二碳六烯酸(DHA))对人结肠癌细胞(HCT116)转移的治疗作用。水动力学直径小于 100nm 的 DMPC/DHA 可保存一个月。在 HCT116 细胞肝转移小鼠模型中静脉注射 DMPC/DHA 后,获得了显著的高治疗效果。组织学分析表明,在体内用 DMPC/DHA 处理的肝转移小鼠模型的肝组织切片中观察到诱导细胞凋亡。此外,在肝转移小鼠模型中用 DMPC/DHA 治疗后获得了延长的生存时间。首次在体内通过组织学和生化分析揭示了 DMPC/DHA 对肝转移无任何药物的治疗作用。